Form 4: Hims & Hers Health Executive Michael Chi Executes Stock Options and Sells Shares Under 10b5-1 Plan

Chief Commercial Officer Michael Chi exercised stock options and sold shares of Hims & Hers Health, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options to acquire 7,500 shares of Class A Common Stock at a price of $13.9 on June 20, 2024.
• On the same day, Chi sold 7,500 shares of Class A Common Stock at a price of $24.5.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Chi directly owns 185,326 shares of Class A Common Stock.
• Chi also directly owns 96,582 stock options.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. Rule 10b5-1 plans allow insiders to trade company stock without being accused of insider trading, as long as the plan is established in good faith and trades are executed according to the plan's pre-determined schedule and terms.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• The vesting schedule of these options is typical, designed to incentivize long-term commitment to the company.
• The use of a 10b5-1 trading plan is a standard practice for executives to manage their stock holdings while avoiding potential insider trading concerns.
• Comparable companies such as Teladoc Health and GoodRx also have executives who utilize similar trading plans.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates